Global Inhaled Nitric Oxide Delivery Systems Market Size, Trends & Growth Opportunity, By Type (Pediatrics, Adult), By End-user (Hospitals, Ambulatory Centers, Clinics), By Region and Forecast till 2027
Report ID : QR1001275 | Industries : Healthcare | Published On :November 2021 | Page Count : 243Global Inhaled Nitric Oxide Delivery Systems Market
The global Inhaled Nitric Oxide Delivery Systems market was valued at USD 247.5 million in 2020 which expected to reach USD 434.2 million by 2027 at a CAGR 6.9% from 2020-2027.
Inhaled Nitric Oxide (NO) Delivery Systems are medical devices that give nitric oxide to patients who have severe breathing issues. Nitric oxide is therapeutically effective in dilating blood vessels and relaxing muscular tension in order to efficiently absorb oxygen in the body. Furthermore, nitric oxide delivery systems are employed to treat neonates with hypoxic respiratory failure.
Market Drivers
Ongoing R&D activities resulting in new application areas in the healthcare industry are projected to present profitable prospects for the expansion of the global inhaled nitric oxide market. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of worldwide significance. COVID-19 has affected approximately 210 nations worldwide.
Know more about this report: request for sample pages
Market Restraints
The rise in the prevalence of respiratory disorders such as COPD and asthma may also be too responsible for the quick growth of the global inhaled nitric oxide delivery system market.
Impact of COVID-19
In the United States, approximately 1.8 million people are infected with coronavirus as of May 2020. Furthermore, the US FDA has approved the emergency use of VERO Biotech's GENOSYL NO delivery device in urgent COVID-19 patients suffering from respiratory failure. These developments are projected to increase the demand for inhaled nitric oxide delivery devices in the country.
Market Segmentation
The Global Inhaled Nitric Oxide Delivery Systems Market is segmented into Type, End-user, Distribution Channel and Growing System. By Type such as Pediatrics, Adult. Further, market is segmented into By End-user such as Hospitals, Ambulatory Centers, and Clinics.
Regional Analysis
Global Inhaled Nitric Oxide Delivery Systems Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America has the largest market share and Regional growth is boosted by an increase in the use of INO therapy, a favorable government initiative, and the presence of advanced medical infrastructure. APAC, on the other hand, had the highest revenue share in 2020 and is expected to maintain this trend during the projection period due to the expanding pediatric population.
Key Players
Various key players are listed in this report such as Mallinckrodt Pharmaceuticals; Getinge; Vero Biotech; LINDE; Beyond Air; NU MED; Bellerophon Therapeutics; Air Liquide Healthcare; Circassia Pharmaceuticals.
Market Taxonomy
By Type
- Pediatrics
- Adult
By End-user
- Hospitals
- Ambulatory Centers
- Clinics
By Region
- North America
- Latin America
- Europe
- China
- Asia Pacific
- Middle East & Africa
Key Questions Addressed by the Report
- What are the Key Opportunities in Global Inhaled Nitric Oxide Delivery Systems Market?
- What will be the growth rate from 2020 to 2027?
- Which segment/region will have highest growth?
- What are the factors that will impact/drive the Market?
- What is the competitive Landscape in the Industry?
- What is the role of key players in the value chain?
Global Inhaled Nitric Oxide Delivery Systems Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Inhaled Nitric Oxide Delivery Systems Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Inhaled Nitric Oxide Delivery Systems Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Type
5.3 Global Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Type
5.3.1 Pediatrics
5.3.2 Adult
6 Global Inhaled Nitric Oxide Delivery Systems Market, By End-user
6.1 Y-o-Y Growth Comparison, By End-user
6.2 Global Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By End-user
6.3 Global Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By End-user
6.3.1 Hospitals
6.3.2 Ambulatory Centers
6.3.3 Clinics
7 Global Inhaled Nitric Oxide Delivery Systems Market, By Application
7.1 Y-o-Y Growth Comparison, By Application
7.2 Global Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Application
7.3 Global Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Application
7.3.1 Hypoxic Respiratory Failure (HRF)
7.3.2. Acute Hypoxemic Respiratory Failure (AHRF)
7.3.4. Others
8 Global Inhaled Nitric Oxide Delivery Systems Market, By Region
8.1 Global Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Region
8.2 Global Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Region
8.3 Global Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Region
9 North America Inhaled Nitric Oxide Delivery Systems Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Type
9.3 North America Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By End-user
9.4 North America Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Application
9.6 North America Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe Inhaled Nitric Oxide Delivery Systems Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Type
10.3 Europe Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By End-user
10.4 Europe Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Application
10.6 Europe Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific Inhaled Nitric Oxide Delivery Systems Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Type
11.3 Asia Pacific Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By End-user
11.4 Asia Pacific Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Application
11.6 Asia Pacific Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America Inhaled Nitric Oxide Delivery Systems Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Type
12.3 Latin America Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By End-user
12.4 Latin America Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Application
12.6 Latin America Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East Inhaled Nitric Oxide Delivery Systems Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Inhaled Nitric Oxide Delivery Systems Market Share Analysis, By Type
13.3 Middle East Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By End-user
13.4 Middle East Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Application
13.6 Middle East Inhaled Nitric Oxide Delivery Systems Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Mallinckrodt Pharmaceuticals
15.1.1 Overview
15.1.2 Types
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Getinge
15.2.1 Overview
15.2.2 Types
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Vero Biotech
15.3.1 Overview
15.3.2 Types
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 LINDE
15.4.1 Overview
15.4.2 Types
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Beyond Air
15.5.1 Overview
15.5.2 Types
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 NU MED
15.6.1 Overview
15.6.2 Types
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Bellerophon Therapeutics
15.7.1 Overview
15.7.2 Types
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Air Liquide Healthcare
15.8.1 Overview
15.8.2 Types
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Circassia Pharmaceuticals
15.9.1 Overview
15.9.2 Types
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies